AGM/EGMMay 12, 2026, 08:12 AM
HUTCHMED Shareholders Pass All Resolutions at 2026 AGM
AI Summary
HUTCHMED (China) Limited announced that all ordinary and special resolutions put to its Annual General Meeting (AGM) held on May 12, 2026, were duly passed by shareholders. Key approvals included the adoption of the 2025 audited financial statements, the re-election of all nine directors, and the re-appointment of PricewaterhouseCoopers as independent auditors. Shareholders also granted mandates for the issuance and repurchase of shares and approved the 2026 Share Option Scheme.
Key Highlights
- Shareholders adopted the audited Financial Statements for the year ended December 31, 2025, with 99.9998% votes for.
- All nine Directors, including Dr Dan Eldar and Dr Weiguo Su, were re-elected with strong shareholder support.
- PricewaterhouseCoopers was re-appointed as Independent Auditors for Hong Kong and US financial reporting (89.7296% for).
- A general mandate was granted to Directors to issue additional shares, with 99.9851% votes for.
- A general mandate was granted to Directors to repurchase shares, with 99.9933% votes for.
- The 2026 Share Option Scheme of the Company was approved by shareholders (90.1613% for).
Price Impact
More from HCM